Skip to content
DataLookout
Menu

NCT06445153

Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words Show 5 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Jul 31, 2027 to Jun 30, 2026
    • Enrollment target: 845 to 844
    • Secondary endpoints: details revised at 11 of 50 entries
    • Site details revised at 1 of 4 sites
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 800 to confirmed 845
    • Primary completion date changed from estimate of Jul 31, 2026 to Jan 15, 2026
    • Site details revised at 4 of 4 sites
    v5
  3. Minor Study description expanded, about 69 wordsv4
  4. Notable Primary completion date: Jul 30, 2025 to Jul 31, 2026
    • Study completion date: Jul 30, 2026 to Jul 31, 2027
    v3
  5. Minor Primary completion date: Oct 30, 2025 to Jul 30, 2025v2 Show 4 more changesShow less
    • Study completion date: Oct 30, 2025 to Jul 30, 2026
    • Secondary endpoints: 47 to 50
    • Study description expanded, about 34 words
    • Site contacts updated at 1 of 4 sites
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Guideline adherence
Timeframe: Up to five days
Postperative delirium- free days
Timeframe: Up to five days

Secondary (50)

Causes of delirium
Changes of Electroencephalography
Blood pressure
Pulse
Heart rhythm
Show 45 moreShow less
Heart rate
Oxygen saturation
Amount of dexmedetomidine
Therapeutic measures against postoperative delirium (POD)
Team meetings on postoperative delirium (POD)
Delirium incidence
Delirium duration
Proportion of patients with adequate adherence
Proportion of patients with good adherence
Number of POD-free days in patients who achieved less than 80% adherence to the guidelines.
Guideline adherence
Number of POD-free days within 7 days
Delirium incidence within 7 days
Anxiety
Pain
Depth of sedation
Functional performance
Concomitant medication
Complications
Infection status
Charlson comorbidity index (CCI)
Change in cognitive status I
Change in cognitive status II
Change in care level for BARMER patients
Change in utilization of inpatient care
Change in Patient-Reported Outcomes Measures (PROMs)
Change in Patient-Reported Experience Measures (PREMs)
Change in the result from the detailed geriatric assessment and the frailty scoring
Length of hospital stay
Length of intensive care unit stay
Discharge type
Length of stay in the recovery room
Duration of surgery
Duration of anesthesia
Recommended therapies
Incidence of Post Intensive Care Syndrome (PICS)
Social data/Paragraph 21 data
Social data
All-cause "mortality"
Direct cost data
Follow-up costs
Utilization of benefits
Personnel resources during the hospital stay
Investment costs
Maintenance costs

Arms and interventions

Control phaseNo intervention

Control phase: in this phase, all study patients receive the standard therapy of the respective study center.

Intervention phaseExperimental

In this phase, the intervention with Digi-POD is made available as Clinical Decision Support System. The intervention consists of providing patients, relatives and caregivers with Digi-POD decision support for the prevention of delirium and treatment decisions for delirium in accordance with the recommendations from the guidelines in addition to the standard therapy of the respective study center.

Other: Intervention with clinical decision support system

Sites

4 sites in 1 country